1-(3-Dimethylaminopropyl)-3-ethylcarbodiimidehydrochloride CAS:25952-53-8

In research and laboratory settings, 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimidehydrochloride is widely utilized for the conjugation of proteins, peptides, and nucleic acids to other molecules and surfaces. Its role in crosslinking biomolecules supports the development of diagnostics, therapeutics, and biomaterials, enabling the creation of novel bioconjugates with specific functionalities and binding properties. Furthermore, this compound serves as a key reagent in peptide synthesis, where it is utilized for activating carboxyl groups in amino acids, facilitating their coupling with amine groups to form peptide bonds. Its use in peptide chemistry supports the preparation of custom peptides, peptide libraries, and peptide conjugates for biological studies, drug discovery, and therapeutic applications. Moreover, 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimidehydrochloride finds application in vaccine development and protein engineering, contributing to the modification and functionalization of immunogenic molecules. By enabling the coupling of antigens and adjuvants, it supports the generation of vaccine candidates and immune-modulating agents for disease prevention and immunotherapy research. Additionally, this compound is utilized in the immobilization of biomolecules onto solid supports and surfaces, playing a crucial role in the development of biosensors, diagnostic assays, and bioanalytical devices. Its ability to facilitate stable covalent linkages supports the construction of functionalized platforms for detecting and studying biological interactions and processes. Overall, 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimidehydrochloride plays a pivotal role in bioconjugation, peptide synthesis, vaccine development, and bioanalytical applications, demonstrating its significance in biomedical research, pharmaceutical sciences, and biotechnology.